Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
David J. Worhunsky(Stanford Medicine), George A. Poultsides(Stanford University), Sepideh Gholami(University of California, Davis), Jeffrey A. Norton(Stanford University), Kristen N. Ganjoo(Stanford Medicine), Mihir Gupta(University of California San Diego), Brendan C. Visser(Stanford Medicine), Thuy B. Tran(Stanford Medicine), Matt van de Rijn(Stanford University)
Cited by 24
Related Papers
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
|Journal of the National Comprehensive Cancer Network|2010|1.2k
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status
|American Journal Of Pathology|2004|662